Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

The Influence of Affect on Cognition

The Influence of Affect on Cognition

Positive affect significantly influences cognitive processes, including evaluation, memory, creativity, and social judgments. Compared to negative affect, positive emotional states promote more favorable interpretations of stimuli, cognitive flexibility, and heuristic processing. These effects highlight emotions' powerful role in shaping how individuals perceive, remember, and interact with the world.Influence on Evaluation and AttributionWhen individuals experience positive affect, they are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Actigraphic patterns, impulsivity and mood instability in bipolar disorder, borderline personality disorder and healthy controls.

Acta psychiatrica Scandinavica·2020

Same author

Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilities.

Journal of intellectual disability research : JIDR·2018

Same author

Re-medicalizing the care of patients with schizophrenia?

L'Encephale·2018

Same author

Variability in phase and amplitude of diurnal rhythms is related to variation of mood in bipolar and borderline personality disorder.

Scientific reports·2018

Same author

Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial.

Bipolar disorders·2017

Same author

Remote mood monitoring for adults with bipolar disorder: An explorative study of compliance and impact on mental health service use and costs.

European psychiatry : the journal of the Association of European Psychiatrists·2017

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Innovation translates into antidepressant effectiveness.

¹University Department of Psychiatry, Warneford Hospital, Headington, Oxford, UK. guy.goodwin@psych.ox.ac.uk

Journal of Psychopharmacology (Oxford, England)

|December 17, 2008

Summary

This summary is machine-generated.

Agomelatine demonstrates efficacy in treating major depression, particularly in severely ill patients. It offers a novel pharmacological profile with an absence of early relapses upon withdrawal, unlike some other antidepressants.

More Related Videos

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: Jul 2, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

Pharmacology
Psychiatry
Clinical Medicine

Background:

Unipolar depression is a leading cause of disability globally.
Current antidepressant treatments have limitations in efficacy and side effect profiles.
Agomelatine represents a novel antidepressant with a unique pharmacological action.

Purpose of the Study:

To evaluate the efficacy of agomelatine in major depression.
To analyze subgroup responses, particularly in severely ill patients.
To assess the relapse prevention and withdrawal effects of agomelatine compared to other antidepressants.

Main Methods:

Pooling of data from short-term, placebo-controlled trials of agomelatine.
Analysis of subgroup responses based on depression severity.
Evaluation of a relapse prevention study and withdrawal effects.

Main Results:

Agomelatine shows efficacy in major depression, with a trend for greater effect size in more severely ill patients.
The drug demonstrates efficacy in maintaining treatment effects.
A notable absence of early relapses and immediate withdrawal symptoms was observed post-agomelatine discontinuation, contrasting with SSRIs and venlafaxine.

Conclusions:

Agomelatine is an effective treatment for major depression, especially in severe cases.
Its novel pharmacological properties offer clinical advantages, including reduced relapse and withdrawal symptoms.
Agomelatine is generally well-tolerated, with dizziness being an occasional side effect.